1例海曲泊帕治疗儿童慢性原发性免疫性血小板减少症的案例分析
A Case Study of Chronic Immune Thrombocytopenia in Children Treated with Hetrombopag
蔡泽政 1梁凤玲 2刘洁 3廖倩倩4
作者信息
- 1. 贵州省黔东南苗族侗族自治州人民医院药剂科,贵州凯里 556000
- 2. 贵州省黔东南苗族侗族自治州人民医院儿科,贵州凯里 556000
- 3. 重庆大学附属江津医院药剂科,重庆 402260
- 4. 桂林市人民医院药学部,广西桂林 541000
- 折叠
摘要
临床医生和临床药师为1 例慢性原发性免疫性血小板减少症患儿制定海曲泊帕治疗方案和监测目标,随后开展的药学监护.通过20 +周的海曲泊帕治疗,患儿血小板达到并维持在目标范围,停药14 周后血小板仍可保持在正常范围.用药期间未见明显药物不良反应.为海曲泊帕治疗儿童慢性原发性免疫性血小板减少症的临床应用实践提供了一定参考.
Abstract
The clinicians and clinical pharmacists developed a treatment regimen and monitoring goals for hetrom-bopog for a child with chronic immune thrombocytopenia,followed by pharmacological care by a clinical pharma-cist.The child's platelets were achieved and maintained in the target range through 20 +weeks of hetrombopog thera-py,and platelets remained in the normal range 14 weeks after discontinuation of the drug.No significant adverse drug reactions were observed during the medication period.It provides a reference for the clinical application practice of hetrombopog in the treatment of chronic immune thrombocytopenia in children.
关键词
儿童/慢性原发性免疫性血小板减少症/海曲泊帕Key words
Pediatric/Chronic immune thrombocytopenia/Hetrombopog引用本文复制引用
出版年
2024
NETL
NSTL
万方数据